|
?:authorAffiliation
|
-
[\'Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.\', \'Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.\', \'Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.\', \'HealthCore, Inc., Wilmington, Delaware, USA.\', \'CVS Health Clinical Trial Services (formerly known as Healthagen), Affiliate of Aetna and Part of CVS Health family of companies, Blue Bell, Pennsylvania, USA.\', \'Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.\', \'HealthPartners, Bloomington, Minnesota, USA.\', \'Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}